The Emerging Role of Mindfulness Meditation as Effective Self-Management Strategy, Part 1: Clinical Implications for Depression, Post-Traumatic Stress Disorder, and Anxiety.

This review of 52 systematic reviews and randomized clinical trials, published up to August 2015, evaluates mindfulness-based interventions for mental health conditions common after military deployment. Adjunctive mindfulness-based cognitive therapy is effective for reducing symptom severity during a current depressive episode and for lowering relapse rates in recovered patients (moderate strength of evidence). Adjunctive mindfulness-based stress reduction improves symptoms, mental health-related quality of life, and mindfulness in veterans with combat PTSD (moderate strength of evidence). Insufficient data exist to recommend mindfulness-based interventions for generalized anxiety disorder. The authors conclude the interventions are safe, portable, and cost-effective as adjuncts to standard care for major depressive disorder and PTSD.

Study at a glance

Abstract

Mindfulness-based interventions (MBIs) have been increasingly utilized in the management of mental health conditions. This first review of a two-part series evaluates the efficacy, mechanism, and safety of mindfulness meditation for mental health conditions frequently seen after return from deployment. Standard databases were searched until August 4, 2015. 52 systematic reviews and randomized clinical trials were included. The Strength of Recommendation (SOR) Taxonomy was used to assess the quality of individual studies and to rate the strength of evidence for each clinical condition. Adjunctive mindfulness-based cognitive therapy is effective for decreasing symptom severity during current depressive episode, and for reducing relapse rate in recovered patients during maintenance phase of depression management (SOR moderate [SOR B]). Adjunctive mindfulness-based stress reduction is effective for improving symptoms, mental health-related quality of life, and mindfulness in veterans with combat post-traumatic stress disorder (PTSD) (SOR B). Currently, there is no sufficient data to recommend MBIs for generalized anxiety disorder (SOR B). MBIs are safe, portable, cost-effective, and can be recommended as an adjunct to standard care or self-management strategy for major depressive disorder and PTSD. Future large, well-designed randomized clinical trials in service members and veterans can help plan for the anticipated increase in demand for behavioral health services.